Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma
In this study, we identified an energy metabolism-related gene GLUD1 potentially contributing to favorable clinical outcomes of IDH-mutant glioma. In glioma, GLUD1 related clinical outcomes and immune landscape were clearer, and more valuable information was provided for immunotherapy.
Authors
- Dandan Zhu (ORCID: https://orcid.org/0000-0003-4609-1238)
- Renzhi Deng (ORCID: https://orcid.org/0009-0002-1574-0987)
- Xuyong Sun (ORCID: https://orcid.org/0000-0002-2098-2510)
- Lei Wang (ORCID: https://orcid.org/0000-0002-8829-0246)
- Ke Qin (ORCID: https://orcid.org/0000-0001-7298-7826)
- Haibin Li (ORCID: https://orcid.org/0009-0004-4062-9353)
- Ning Wen (ORCID: https://orcid.org/0000-0001-9059-2406)
- Jianying Qin
- Jianhui Dong
- Jihua Wu
Institutions
- Guangxi University (CN)
- Guangxi Medical University (CN)
- Guangxi Science and Technology Department (CN)
Publication Details
- Journal
- BMC Neurology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1186/s12883-024-03787-w
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00